ArchiMed looks to replicate impressive Polyplus success with investment in DNA producer Xpress Biologics

• Emily Lai
• October 5, 2021

Healthcare-focused buyout house ArchiMed has bought into Belgium-based Xpress Biologics to finance a 10x expansion of its production capacity, the firm said. The post ArchiMed looks to replicate impressive Polyplus success with investment in DNA producer